The findings may eventually help vaccine developers predict flu strain evolution. (sciencenews.org)
That could be a serious concern for vaccine developers, says John LaMontagne, director of the division of Microbiology and Infectious Disease at the National Institute of Allergy and Infectious Diseases. (sciencemag.org)
Broadly neutralizing HIV antibodies have been isolated from chronically infected people, giving HIV vaccine developers hope that they could stimulate production of such antibodies in healthy people as protection against the virus. (sciencedaily.com)